Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Is Fabre-Kramer’s Gepirone Antidepressant Rising From The Dead After 8 Years?

Related Content

Fabre-Kramer/GSK Submit Gepirone ER For Major Depressive Disorder

May 08 2007

Third Strike For Gepirone ER: Fabre-Kramer/GSK Antidepressant “Not Approvable” Again

Nov 05 2007

Related Companies

Fabre-Kramer Pharmaceuticals

GSK plc

Merck & Co., Inc.

Bristol Myers Squibb Company

Schering-Plough

Merck & Co., Inc.

Additional Topics

United States Regulation Advisory Committees Drug Approval Standards BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window